5:12 PM
 | 
Oct 09, 2009
 |  BC Extra  |  Company News

Fusilev gets complete response

Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) received a complete response letter from FDA for an sNDA for Fusilev levoleucovorin injection to treat advanced metastatic colorectal...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >